Hyphens Pharma International Limited (SGX:1J5)
Singapore · Delayed Price · Currency is SGD 0.3600
0.00 (0.00%)
At close: Sep 11, 2026
SGXC:1J5 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SGXC:1J5 stock has a consensus rating of "Strong Buy" and an average price target of $0.45. The average 1-year stock price forecast is 25.00% higher than the current stock price, while the lowest is $0.43 (+19.44%) and the highest is $0.46 (+27.78%).
Price Target: $0.45 (+25.00%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SGXC:1J5 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Nov '24 | Mar '25 | Aug '25 | Mar '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Phillip Securities No rating | Phillip Securities | Buy Maintains $0.46 | Buy | Maintains | $0.46 | +27.78% | Aug 24, 2026 |
Financial Forecast
Revenue This Year
185.08M
from 177.37M
Increased by 4.35%
Revenue Next Year
199.50M
from 185.08M
Increased by 7.79%
EPS This Year
0.04
from 0.02
Increased by 112.90%
EPS Next Year
0.04
from 0.04
Increased by 10.23%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SGD.